Skip to main content
Clinical Trials/NCT07338643
NCT07338643Not yet recruitingNot Applicable

The Auxiliary Effect of Artificial Intelligence in the Detection of Precancerous Lesions in Proximal Colon Cancer: A Multicenter Randomized Controlled Study

Limian Er1 site in 1 country1,200 target enrollmentStarted: February 26, 2026Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
1,200
Locations
1
Primary Endpoint
Adenoma detection rate

Study Overview

Brief Summary

The investigators conducted a multicenter randomized controlled trial to explore the adjuvant effect of artificial intelligence in the detection of precancerous lesions in the proximal colon.This is a prospective, multicenter, single-blind, parallel randomized controlled trial.During the colonoscopy retraction process, the investigators aimed to compare the detection rates of proximal colon adenomas with and without the assistance of an AI(Artificial Intelligence) diagnostic device.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 1.Patients with symptoms such as abdominal pain, black stools, constipation, or diarrhea undergo colonoscopy for diagnostic purposes.

Exclusion Criteria

  • Those with inflammatory bowel disease, colorectal cancer and surgical history, as well as those with familial polyposis syndrome
  • Those with intestinal obstruction or malignant tumors
  • Patients with colorectal lesions that need to be treated in stages.
  • Other contraindications for colonoscopy examination.

Outcomes

Primary Outcomes

Adenoma detection rate

Time Frame: Day 1

The proportion of patients who have at least one adenoma detected during colonoscopy examination

Average adenoma detection rate

Time Frame: Day 1

The result is the number of adenomas detected by colonoscopy divided by the total number of colonoscopies performed.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Limian Er
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Limian Er

The director of the Endoscopy Department of the Fourth Hospital of Hebei Medical University

Hebei Medical University Fourth Hospital

Study Sites (1)

Loading locations...

Similar Trials